Practice, Progress and Future Directions for Physical Therapies in Huntington's Disease

被引:6
|
作者
Busse, Monica [1 ]
Khalil, Hanan [1 ]
Brooks, Simon [2 ]
Quinn, Lori [1 ]
Rosser, Anne [3 ]
机构
[1] Cardiff Univ, Sch Healthcare Studies, Ty Dewisant,Heath Pk Site, Cardiff CF14 4XN, S Glam, Wales
[2] Cardiff Univ, Sch Biosci, Cardiff Brain Repair Grp, Cardiff, S Glam, Wales
[3] Cardiff Univ, Sch Biosci, Inst Psychol Med & Clin Neurosci, Sch Med & Cardiff Brain Repair Grp, Cardiff, S Glam, Wales
基金
英国医学研究理事会;
关键词
Huntington's disease; chorea; exercise; physical activity; physiotherapy; physical therapy; rehabilitation;
D O I
10.3233/JHD-120025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Physical therapies and exercise may have potential as a disease modifying agent in Huntington's disease (HD) and in recent years, there have been several small scale feasibility studies that have shown benefit as a result of physical interventions. When evaluating complex physical interventions, a phased approach using mixed methodology designs that report specific intervention components, adherence, acceptability, adverse events and defined intervention protocols is important for replication and planning of future trials and to ensure potential for implementation in clinical practice. A narrative review of the available literature related to physical activity, physical therapy and exercise in people with HD was performed using a population, intervention, comparison and outcome (PICO) approach. Eight studies met specific inclusion criteria and were reviewed in terms of their systematic conduct and reporting standards. All of the studies (n = 8) provided details of intervention including location and duration. The majority of interventions included balance training activities in combination with other complex activities of daily living that required therapist supervision. Two of the interventions were home based, the remainder were facility or hospital based. None of the studies reported adverse events whilst only 3/8 reported adherence rates which were ranging from 60-80%. In general, limited detail was provided on the specific individual components of the interventions. This review of primary publications and conference proceedings, suggests that researchers working in the field need to focus on clearer reporting of intervention protocols so as to generate a better understanding of the impact of exercise and physical therapies on the symptoms of HD, as well as any potential synergistic role alongside the impending disease-modifying interventions.
引用
收藏
页码:175 / 185
页数:11
相关论文
共 50 条
  • [1] Antibody-based therapies for Huntington's disease: current status and future directions
    Denis, Helena L.
    David, Linda S.
    Cicchetti, Francesca
    [J]. NEUROBIOLOGY OF DISEASE, 2019, 132
  • [2] A Scoping Review of Palliative Care for Adults with Huntington's Disease: Current Practice and Future Directions
    El-Sourady, Maie
    Martin, Sara
    Wong, Hong-nei
    Carroll, Thomas
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2022, 25 (03) : 488 - 505
  • [3] Tolerance-inducing therapies in coeliac disease - mechanisms, progress and future directions
    Sollid, Ludvig M.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (05) : 335 - 347
  • [4] Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions
    Ludvig M. Sollid
    [J]. Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 335 - 347
  • [5] Podocyte-targeted therapies - progress and future directions
    Meliambro, Kristin
    He, John C.
    Campbell, Kirk N.
    [J]. NATURE REVIEWS NEPHROLOGY, 2024, 20 (10) : 643 - 658
  • [6] Myopathy: Recent Progress, Current Therapies, and Future Directions
    Mammen, Andrew L.
    Roda, Ricardo H.
    Leung, Doris G.
    [J]. NEUROTHERAPEUTICS, 2018, 15 (04) : 837 - 839
  • [7] Myopathy: Recent Progress, Current Therapies, and Future Directions
    Andrew L. Mammen
    Ricardo H. Roda
    Doris G. Leung
    [J]. Neurotherapeutics, 2018, 15 : 837 - 839
  • [8] Clinical Practice Guidelines for Physical Therapy for Huntington's Disease
    Kloos, Anne
    Fritz, Nora
    Quinn, Lori
    Rao, Ashwini K.
    Busse, Monica
    Kegelmeyer, Deb
    [J]. NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 3 - 3
  • [9] Future directions in research with presymptomatic individuals carrying the gene for Huntington's disease
    Georgiou-Karistianis, N
    Smith, E
    Bradshaw, JL
    Chua, P
    Lloyd, J
    Churchyard, A
    Chiu, E
    [J]. BRAIN RESEARCH BULLETIN, 2003, 59 (05) : 331 - 338
  • [10] Electrophysiological measures as potential biomarkers in Huntington's disease: Review and future directions
    Nguyen, Lan
    Bradshaw, John L.
    Stout, Julie C.
    Croft, Rodney J.
    Georgiou-Karistianis, Nellie
    [J]. BRAIN RESEARCH REVIEWS, 2010, 64 (01) : 177 - 194